Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells

Journal of Cell Science

Volumn 117, Issue 8, 2004, Pages 1365-1379

  Singh, Amar B ^a   Tsukada, Toshiaki ^a   Zent, Roy ^a   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

MDCK II; Membrane anchored HB EGF; Scattering; Transepithelial resistance; Tubulogenesis

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LIGAND; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN PRECURSOR; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL STRAIN; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE DELETION; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; CELL COMMUNICATION; CELL LINE; CELL MOVEMENT; CHICK EMBRYO; COLLAGEN; DOGS; ELECTRIC IMPEDANCE; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE DELETION; HEPATOCYTE GROWTH FACTOR; PRECIPITIN TESTS; PROTEIN PRECURSORS; SOLUBILITY;

ANIMALIA;

EID: 2342446235     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01037     Document Type: Article

References (73)

1. Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H. et al. (2002). Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8, 35-40.
2. Balkovetz, D. F. (1998). Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis. Microsc. Res. Tech. 43, 456-463.
3. Bancroft, C. C., Chen, Z., Yeh, J., Sunwoo, J. B., Yeh, N. T., Jackson, S., Jackson, C. and van Waes, C. (2002). Effects of pharmacologic antagonists of epidermal growth factor receptor. PI3K and MEK sipal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer 99, 538-548.
4. Bardelli, A., Pugliese, L. and Comoglio, P. M. (1997). "Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection. Biochim. Biophys. Acta 1333, M41-M51.
5. Barros, E., Santos, O., Matsumoto, K., Nakamura, T. and Nigam, S. (1995). Differential Tubulogenic and Branching Morphogenetic Activities of Growth Factors: Implications for Epithelial Tissue Development. Proc. Natl. Acad. Sci. USA 92, 4412-4416.
6. Bauer, A., Lickert, H., Kemler, R. and Stappert, J. (1998). Modification of the E-cadherin-Catenin Complex in Mitotic Madin-Darby Canine Kidney Epithelial Cells. J. Biol. Chem. 273, 28314-28321.
7. Braga, V. M. (2002). Cell-cell adhesion and signalling. Curr. Opin. Cell Biol. 14, 546-556.
8. Carpenter, G. (2000). The EGF receptor: a nexus for trafficking and signaling. Bioessays 22, 697-707.
9. Cattan, N., Rochet, N., Mazeau, C., Zanghellini, E., Mari, B., Chauzy, C., Stora de Novion, H., Amiel, J., Lagrange, J. L., Rossi, B. et al. (2001). Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors. Br. J. Cancer 85, 1412-1417.
10. Chen, J.-K., Capdevila, J. and Harris, R. C. (2002). Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells. Proc. Natl. Acad. Sci. USA 99, 6029-6034.
11. Datta, S. R., Brunet, A. and Greenberg, M. E. (1999). Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
12. Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., Pawson, T., Goldfarb, M. and Yancopoulos, G. D. (1994). Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266, 816-819.
13. Dhawan, P. and Richmond, A. (2002). A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma Cells. J. Biol. Chem. 277, 7920-7928.
14. Elenius, K., Paul, S., Allison, G., Sun, J. and Klagsbrun, M. (1997). Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16, 1268-1278.
15. Faull, R. J., Stanley, J. M., Fraser, S., Power, D. A. and Leavesley, D. I. (2001). HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int. 59, 614-624.
16. Fukuyama, R. and Shimizu, N. (1991). Detection of epidermal growth factor receptors and E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn. J. Cancer Res. 82, 8-11.
17. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E. and Taniguchi, N. (1995). Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6, 967-980.
18. Grisendi, S., Arpin, M. and Crepaldi, T. (1998). Effect of hepatocyte growth factor on assembly of zonula occludens-1 protein at the plasma membrane. J. Cell Physiol. 176, 465-471.
19. Gumbiner, B. M. (1996). Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84. 345-357.
20. Hauguel-DeMouzon, S., Csermely, P., Zoppini, G. and Kahn, C. R. (1992). Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity. J. Cell Physiol. 150, 180-187.
21. Higashiyama, S., Abraham, J., Miller, J., Fiddes, J. and Klagsbrun, M. (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251, 936-939.
22. Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M. and Mekada, E. (1995). The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol. 128, 929-938.
23. Higashiyama, S., Lau, K., Besner, G., Abraham, J. and Klagsbrun, M. (1992). Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 267, 6205-6212.
24. Hirata, M., Umata, T., Takahashi, T., Ohnuma, M., Miura, Y., Iwamoto, R. and Mekada, E. (2001). Identification of serum factor inducing ectodomain shedding of proHB-EGF and studies of noncleavable mutants of proHB-EGF. Biochem. Biophys. Res. Comm. 283, 915-922.
25. Hopkins, A. M., Li, D., Mrsny, R. J., Walsh, S. V. and Nusrat, A. (2000). Modulation of tight junction function by G protein-coupled events. Adv. Drug Deliv. Rev. 41, 329-340.
26. Iwamoto, R., Handa, K. and Mekada, E. (1999). Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem. 274, 25906-25912.
27. Iwamoto, R. and Mekada, E. (2000). Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11, 335-344.
28. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S. et al. (1998). A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260-7272.
29. Jo, M., Stolz, D. B., Esplen, J. E., Dorko, K., Michalopoulos, G. K. and Strom, S. C. (2000). Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J. Biol Chem. 275, 8806-8811.
30. Kamei, T., Matozaki, T., Sakisaka, T., Kodama, A., Yokoyama, S., Peng, Y. F., Nakano, K., Takaishi, K. and Takai, Y. (1999). Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells-regulation by Rho, Rac and Rab small G proteins. Oncogene 18, 6776-6784.
31. Kanai, N., Fujita, Y., Kakuta, T. and Saito, A. (1999). The effects of various extracellular matrices on renal cell attachment to polymer surfaces during the development of biourtificial renal tubules. Artif. Organs 23, 114-118.
32. Khwaja, A., Lehmann, K., Marte, B. M. and Downward, J. (1998). Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem. 273, 18793-18801.
33. Kimber, S. J. (2000). Molecular interactions at the maternal-embryonic interface during the early phase of implantation. Semin. Reprod. Med. 18, 237-253.
34. Lagaudriere-Gesbert, C., Naour, F. L., Lebel-Binay, S., Billard, M., Lemichez, E., Boquet, P., Boucheix, C., Conjeaud, H. and Rubinstein, E. (1997). Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell. Immunol. 182, 105-112.
35. Liang, C.-C. and Chen, H.-C. (2001). Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha 2 expression that is involved in cell scattering. J. Biol. Chem. 276, 21146-21152.
36. Massague, J. and Pandiella, A. (1993). Membrane-anchored growth factors. Annu. Rev. Biochem. 62, 515-541.
37. Matsumoto, K. and Nakamura, T. (2001). Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 59, 2023-2038.
38. Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T. and Salgia, R. (2002). Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13, 41-59.
39. Mitic, L. L. and Anderson, J. M. (1998). Molecular architecture of tight junctions. Annu. Rev. Physiol. 60, 121-142.
40. Molitoris, B. A. and Wagner, M. C. (1996). Surface membrane polarity of proximal tubular cells: alterations as a basis for malfunction. Kidney Int. 49, 1592-1597.
41. Nakamura, K., Iwamoto, R. and Mekada, E. (1995). Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell Biol. 129, 1691-1705.
42. Nakamura, K., Mitamura, T., Takahashi, T., Kobayashi, T. and Mekada, E. (2000). Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J. Biol. Chem. 275, 18284-18290.
43. Nishi, E., Prat, A., Hospital, V., Elenius, K. and Klagsbrun, M. (2001). N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J. 20, 3342-3350.
44. Nishida, M., Miyagawa, J., Yamashita, S., Higashiyama, S., Nakata, A., Ouchi, N., Tamura, R., Yamamori, K., Kihara, S., Taniguchi, N. et al. (2000). Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation. Arterioscler. Thromb. Vasc. Biol. 20, 1236-1243.
45. Okano, J., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K. and Nakagawa, H. (2000). Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275, 30934-30942.
46. Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D. and Tarnawski, A. S. (2002). Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8, 289-293.
47. Paria, B., Elenius, K., Klagsbrun, M. and Dey, S. (1999). Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation. Development 126, 1997-2005.
48. Paumelle, R., Tulasne, D., Leroy, C., Coll, J., Vandenbunder, B. and Fafeur, V. (2000). Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells. Mol. Biol. Cell 11, 3751-3763.
49. Piepkorn, M., Pittelkow, M. R. and Cook, P. W. (1998). Autocrine regulation of keratinocytes: the emerging role of hparin binding, epidermal growth factor related growth factors. J. Invest. Dermatol. 111, 715-721.
50. Pollack, A. L., Runyan, R. B. and Mostov, K. E. (1998). Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis. Der. Biol. 204, 64-79.
51. Pollard, J. W. (2001). Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res. 3, 230-237.
52. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C. and Ullrich, A. (1999). EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888.
53. Raab, G. and Klagsbrun, M. (1997). Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1333, F179-F199.
54. Racusen, L. C. (1997). Pathology of acute renal failure: structure/function correlations. Adv. Ren. Replace. Ther. 4, 3-16.
55. Riese, D. J., II, Kim, E. D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G. D. and Stern, D. F. (1996). The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 271, 20047-20052.
56. Scheving, L. A., Stevenson, M. C., Taylormoore, J. M., Traxler, P. and Russell, W. E. (2002). Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem. Biophss. Res. Commun. 290, 197-203.
57. Schoenenberger, C. A., Zuk, A., Kendall, D. and Matlin, K. S. (1991). Multilayering and loss of apical polarity in MDCK cells transformed with viral K-ras. J. Cell Biol. 112, 873-889.
58. Sipeki, S., Bander, E., Buday, L., Farkas, G., Bacsy, E., Ways, D. K. and Farago, A. (1999). Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. Cell. Signal. 11, 885-890.
59. Stella, M. C. and Comoglio, P. M. (1999). HGF: a multifunctional growth factor controlling cell scattering. Int. J. Biochem. Cell Biol. 31, 1357-1362.
60. Stuart, R. O., Barros, E. J., Ribeiro, E. and Nigam, S. K. (1995). Epithelial tubulogenesis through branching morphogenesis: relevance to collecting system development. J. Am. Soc. Nephrol. 6, 1151-1159.
61. Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A. et al. (2002). Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277, 12838-12845.
62. Sutton, T. A. and Molitoris, B. A. (1998). Mechanisms of cellular injury in ischemic acute renal failure. Semin. Nephrol. 18, 490-497.
63. Suzuki, M., Raab, G., Moses, M. A., Fernandez, C. A. and Klagsbrun, M. (1997). Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272, 31730-31737.
64. Takemura, T., Hino, S., Murata, Y., Yanagida, H., Okada, M., Yoshioka, K. and Harris, R. C. (1999). Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability. Kidney Int. 55, 71-81.
65. Takemura, T., Kondo, S., Homma, T., Sakai, M. and Harris, R. C. (1997). The membrane-bound form of heparin-binding epidermal growth factor-like Irowth factor promotes survival of cultured renal epithelial cells. J. Biol. Chem. 272, 31036-31042.
66. Tanimura, S., Chatani, Y., Hoshino, R., Sato, M., Watanabe, S., Kataoka, T., Nakamura, T. and Kohno, M. (1998). Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering. Oncogene 17, 57-65.
67. Tokumaru, S., Higashiyama, S., Endo, T., Nakagawa, T., Miyagawa, J. I., Yamamori, K., Hanakawa, Y., Ohmoto, H., Yoshino, K., Shirakata, Y. et al. (2000). Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151, 209-220.
68. Tsukamoto, T. and Nigam, S. K. (1999). Cell-cell dissociation upon epithelial cell scattering requires a step mediated by the proteasome. J. Biol. Chem. 274, 24579-24584.
69. Werb, Z. and Yan, Y. (1998). A cellular striptease act. Science 282, 1279-1280.
70. Yan, Y., Shirakabe, K. and Werb, Z. (2002). The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158, 221-226.
71. Yoshimoto, Y. and Imoto, M. (2002). Induction of EGF-dependent apoptosis by vacuolar-type H+-ATPase inhibitors in A431 cells overexpressing the EGF receptor. Exp. Cell Res. 279, 118-127.
72. Yu, W.-H., Woessner, J. F., Jr, McNeish, J. D. and Stamenkovic, I. (2002). CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307-323.
73. Zhang, Y. W. and Vande Woude, G. F. (2003). HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell Biochem. 88, 408-417.